Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Etilefrine hydrochloride | 943-17-9 | 99.9% | C10H16ClNO2 | 100 MG
SDP

Catalog No. 5000432479
Encompass_Preferred

Etilefrine hydrochloride is a sympathetic nerve agonist and AMPK activator that selectively targets α1/β1 adrenergic receptors. It stimulates α1 adrenergic receptors, leading to contraction of vascular smooth muscle and increased peripheral resistance. It also stimulates β1 receptors to enhance myocardial contractility and increase heart rate, thereby increasing blood pressure and improving cardiac output. Etilefrine hydrochloride also bidirectionally regulates the AMPK/Akt pathway and modulates the phosphorylation levels.

  • Sympathetic nerve agonist and AMPK activator
  • Selectively targets α1/β1 adrenergic receptors
  • Increases blood pressure and improves cardiac output
  • Bidirectionally regulates the AMPK/Akt pathway
  • Applicable in cardiovascular research for conditions like postural hypotension, chylothorax, and improving low cardiac output

Catalog No. 50-004-32479 Supplier Medchemexpress LLC Supplier No. HYA0144A100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Etilefrine hydrochloride is a sympathetic nerve agonist and AMPK activator that selectively targets α1/β1 adrenergic receptors. It stimulates α1 adrenergic receptors, leading to contraction of vascular smooth muscle and increased peripheral resistance. It also stimulates β1 receptors to enhance myocardial contractility and increase heart rate, thereby increasing blood pressure and improving cardiac output. Etilefrine hydrochloride also bidirectionally regulates the AMPK/Akt pathway and modulates the phosphorylation levels.

  • Sympathetic nerve agonist and AMPK activator
  • Selectively targets α1/β1 adrenergic receptors
  • Increases blood pressure and improves cardiac output
  • Bidirectionally regulates the AMPK/Akt pathway
  • Applicable in cardiovascular research for conditions like postural hypotension, chylothorax, and improving low cardiac output

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.